Sponsor pipeline

Fifth Affiliated Hospital, Sun Yat-Sen University clinical trial pipeline

Get alerts when Fifth Affiliated Hospital, Sun Yat-Sen University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine · Nasopharyngeal Carcinoma

    Trial status changed: Recruiting → Withdrawn

    Also in this update: Primary completion moved earlier from Dec 1, 2026 to Mar 31, 2026; Study completion moved earlier from Jan 1, 2027 to Mar 31, 2026

    Fifth Affiliated Hospital, Sun Yat-Sen UniversityPhase 2 NCT05290194 Registry history of NCT05290194 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 2
2
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Fifth Affiliated Hospital, Sun Yat-Sen University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free